Cargando…

Ex-vivo quantitative susceptibility mapping of human brain hemispheres

Ex-vivo brain quantitative susceptibility mapping (QSM) allows investigation of brain characteristics at essentially the same point in time as histopathologic examination, and therefore has the potential to become an important tool for determining the role of QSM as a diagnostic and monitoring tool...

Descripción completa

Detalles Bibliográficos
Autores principales: Evia, Arnold M., Kotrotsou, Aikaterini, Tamhane, Ashish A., Dawe, Robert J., Kapasi, Alifiya, Leurgans, Sue E., Schneider, Julie A., Bennett, David A., Arfanakis, Konstantinos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5737971/
https://www.ncbi.nlm.nih.gov/pubmed/29261693
http://dx.doi.org/10.1371/journal.pone.0188395
_version_ 1783287602773753856
author Evia, Arnold M.
Kotrotsou, Aikaterini
Tamhane, Ashish A.
Dawe, Robert J.
Kapasi, Alifiya
Leurgans, Sue E.
Schneider, Julie A.
Bennett, David A.
Arfanakis, Konstantinos
author_facet Evia, Arnold M.
Kotrotsou, Aikaterini
Tamhane, Ashish A.
Dawe, Robert J.
Kapasi, Alifiya
Leurgans, Sue E.
Schneider, Julie A.
Bennett, David A.
Arfanakis, Konstantinos
author_sort Evia, Arnold M.
collection PubMed
description Ex-vivo brain quantitative susceptibility mapping (QSM) allows investigation of brain characteristics at essentially the same point in time as histopathologic examination, and therefore has the potential to become an important tool for determining the role of QSM as a diagnostic and monitoring tool of age-related neuropathologies. In order to be able to translate the ex-vivo QSM findings to in-vivo, it is crucial to understand the effects of death and chemical fixation on brain magnetic susceptibility measurements collected ex-vivo. Thus, the objective of this work was twofold: a) to assess the behavior of magnetic susceptibility in both gray and white matter of human brain hemispheres as a function of time postmortem, and b) to establish the relationship between in-vivo and ex-vivo gray matter susceptibility measurements on the same hemispheres. Five brain hemispheres from community-dwelling older adults were imaged ex-vivo with QSM on a weekly basis for six weeks postmortem, and the longitudinal behavior of ex-vivo magnetic susceptibility in both gray and white matter was assessed. The relationship between in-vivo and ex-vivo gray matter susceptibility measurements was investigated using QSM data from eleven older adults imaged both antemortem and postmortem. No systematic change in ex-vivo magnetic susceptibility of gray or white matter was observed over time postmortem. Additionally, it was demonstrated that, gray matter magnetic susceptibility measured ex-vivo may be well modeled as a linear function of susceptibility measured in-vivo. In conclusion, magnetic susceptibility in gray and white matter measured ex-vivo with QSM does not systematically change in the first six weeks after death. This information is important for future cross-sectional ex-vivo QSM studies of hemispheres imaged at different postmortem intervals. Furthermore, the linear relationship between in-vivo and ex-vivo gray matter magnetic susceptibility suggests that ex-vivo QSM captures information linked to antemortem gray matter magnetic susceptibility, which is important for translation of ex-vivo QSM findings to in-vivo.
format Online
Article
Text
id pubmed-5737971
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-57379712017-12-29 Ex-vivo quantitative susceptibility mapping of human brain hemispheres Evia, Arnold M. Kotrotsou, Aikaterini Tamhane, Ashish A. Dawe, Robert J. Kapasi, Alifiya Leurgans, Sue E. Schneider, Julie A. Bennett, David A. Arfanakis, Konstantinos PLoS One Research Article Ex-vivo brain quantitative susceptibility mapping (QSM) allows investigation of brain characteristics at essentially the same point in time as histopathologic examination, and therefore has the potential to become an important tool for determining the role of QSM as a diagnostic and monitoring tool of age-related neuropathologies. In order to be able to translate the ex-vivo QSM findings to in-vivo, it is crucial to understand the effects of death and chemical fixation on brain magnetic susceptibility measurements collected ex-vivo. Thus, the objective of this work was twofold: a) to assess the behavior of magnetic susceptibility in both gray and white matter of human brain hemispheres as a function of time postmortem, and b) to establish the relationship between in-vivo and ex-vivo gray matter susceptibility measurements on the same hemispheres. Five brain hemispheres from community-dwelling older adults were imaged ex-vivo with QSM on a weekly basis for six weeks postmortem, and the longitudinal behavior of ex-vivo magnetic susceptibility in both gray and white matter was assessed. The relationship between in-vivo and ex-vivo gray matter susceptibility measurements was investigated using QSM data from eleven older adults imaged both antemortem and postmortem. No systematic change in ex-vivo magnetic susceptibility of gray or white matter was observed over time postmortem. Additionally, it was demonstrated that, gray matter magnetic susceptibility measured ex-vivo may be well modeled as a linear function of susceptibility measured in-vivo. In conclusion, magnetic susceptibility in gray and white matter measured ex-vivo with QSM does not systematically change in the first six weeks after death. This information is important for future cross-sectional ex-vivo QSM studies of hemispheres imaged at different postmortem intervals. Furthermore, the linear relationship between in-vivo and ex-vivo gray matter magnetic susceptibility suggests that ex-vivo QSM captures information linked to antemortem gray matter magnetic susceptibility, which is important for translation of ex-vivo QSM findings to in-vivo. Public Library of Science 2017-12-20 /pmc/articles/PMC5737971/ /pubmed/29261693 http://dx.doi.org/10.1371/journal.pone.0188395 Text en © 2017 Evia et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Evia, Arnold M.
Kotrotsou, Aikaterini
Tamhane, Ashish A.
Dawe, Robert J.
Kapasi, Alifiya
Leurgans, Sue E.
Schneider, Julie A.
Bennett, David A.
Arfanakis, Konstantinos
Ex-vivo quantitative susceptibility mapping of human brain hemispheres
title Ex-vivo quantitative susceptibility mapping of human brain hemispheres
title_full Ex-vivo quantitative susceptibility mapping of human brain hemispheres
title_fullStr Ex-vivo quantitative susceptibility mapping of human brain hemispheres
title_full_unstemmed Ex-vivo quantitative susceptibility mapping of human brain hemispheres
title_short Ex-vivo quantitative susceptibility mapping of human brain hemispheres
title_sort ex-vivo quantitative susceptibility mapping of human brain hemispheres
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5737971/
https://www.ncbi.nlm.nih.gov/pubmed/29261693
http://dx.doi.org/10.1371/journal.pone.0188395
work_keys_str_mv AT eviaarnoldm exvivoquantitativesusceptibilitymappingofhumanbrainhemispheres
AT kotrotsouaikaterini exvivoquantitativesusceptibilitymappingofhumanbrainhemispheres
AT tamhaneashisha exvivoquantitativesusceptibilitymappingofhumanbrainhemispheres
AT dawerobertj exvivoquantitativesusceptibilitymappingofhumanbrainhemispheres
AT kapasialifiya exvivoquantitativesusceptibilitymappingofhumanbrainhemispheres
AT leurganssuee exvivoquantitativesusceptibilitymappingofhumanbrainhemispheres
AT schneiderjuliea exvivoquantitativesusceptibilitymappingofhumanbrainhemispheres
AT bennettdavida exvivoquantitativesusceptibilitymappingofhumanbrainhemispheres
AT arfanakiskonstantinos exvivoquantitativesusceptibilitymappingofhumanbrainhemispheres